Work

Phase 1/2 Study of Venetoclax with Low-Dose Cytarabine in Treatment-Naive, Elderly Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy: 1-Year Outcomes

Year: 2017

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.890.890

Authors: Andrew Wei, Stephen A. Strickland, Gail J. Roboz, Jing-Zhou Hou, Walter Fiedler, Tara L. Lin, Roland B. Walter, Anoop Enjeti, Brenda Chyla, Relja Popovic, Kaffa Fakouhi, Pooja Shah, Martin Dunbar, Tu Xu, Mack Mabry, John Hayslip

Institutions: The Alfred Hospital, Monash University, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Weill Cornell Medicine, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg, University of Kansas Medical Center, Fred Hutch Cancer Center, Calvary Mater Newcastle Hospital, University of Newcastle Australia, AbbVie (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2909289870

Cites:

Cited by: 58

Related to: 10